Navigenics Outlines Focus on Corporate Wellness Programs to Sell its Genomic Screening Services
January 26, 2011
Navigenics Outlines Focus on Corporate Wellness Programs to Sell its Genomic Screening Services
"Employers are overlooked but play a central role in a lot of primary care screenings that happen in the US today," Vance Vanier, CEO of Navigenics, said at a conference on personalized medicine last week in Mountain View, Calif.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Scripps Study Finds Little Impact of DTC Genomics on Consumer Behavior
January 12, 2011 / Pharmacogenomics Reporter - Personalized Medicine in 2012: Industry Takes a Wait-and-See Approach Due to Market Unknowns
January 9, 2013 / Pharmacogenomics Reporter - With Decode Purchase, Amgen Gains Genetics Expertise, Consumers Lose DTC Testing Option
December 12, 2012 / Pharmacogenomics Reporter - With Navigenics Purchase, LifeTech Speeds Entry into Molecular Diagnostics Space
July 18, 2012 / Pharmacogenomics Reporter - UF to Genotype All Comers at Cath Lab to Personalize Treatment with Plavix, Eventually Other Drugs
June 27, 2012 / Pharmacogenomics Reporter